On ECHEMI

Pharmaffiliates Analytics & Synthetics (P) Ltd

India
Favorite Supplier
 388 people visit

Company Profile

Pharmaffiliates Analytics & Synthetics (P) Ltd, is an integrated Contract Research Organisation (CRO) services provider offering its expertise in Custom synthesis (Reference standards, Impurities, Metabolites, Deuterated compounds and Phyto standards), Analytical research (PH Buffer Solutions, Method development, Validation), Stability studies, Formulation & Development (New Drug Delivery System), Quality assurance and Regulatory services with a right blend of competent people, state of the art infrastructure facilities, cutting-edge technology and certified processes to pump your development pipeline with time and cost advantages. Our expertise will also enable you to combat in the highly competitive markets and also in acquiring the niche segments. We desire to be your strategic partner for outsourcing and help you right from strategic planning of CMC blue-print to accelerating the filing and representation for NDAs and ANDAs submitted in any regulated and semi-regulated markets which can reduce your time and efforts for focusing them in your core areas of operations.

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone

Atorvastatin Dehydro Lactone;3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone;5-(4-fluorophenyl)-1-[2-[(2S)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide;SCHEMBL4980905;ZINC67664918;1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide;1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide (Atorvastatin eliminated Lactone);5-(4-fluorophenyl)-2-isopropyl-1-[2-((S)-6-oxo-3,6-dihydro-2H-pyran-2-y1)-ethyl]-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;5-(4-fluorophenyl)-2-isopropyl-1-[2-((S)-6-oxo-3,6-dihydro-2H-pyran-2-yl)-ethyl]-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;5-(4-fluorophenyl)-2-isopropyl-1-[2-((S)-6-oxo-3,6-dihydro-2H-pyran-2-yl)-ethyl]4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
442851-50-5 Inquiry

5-Oxorosuvastatin Methyl Ester

6-Heptenoic acid,7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-,methyl ester,(3R,6E)-;6-Heptenoic acid,7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-,methyl ester,[R-(E)]-;Methyl (3R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoate
147118-39-6 Inquiry

Acyclovir Monophosphate

acyclo-GMP;acycloguanosine monophosphate;acyclovir monophosphate;UNII-6J91QR22O8;6J91QR22O8;6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-(phosphonooxy)ethoxy)methyl)-;2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl dihydrogen phosphate
66341-16-0 Inquiry

Amoxicillin Trihydrate - Impurity C

4-Thiazolidinecarboxylic acid,2-[5-(4-hydroxyphenyl)-3,6-dioxo-2-piperazinyl]-5,5-dimethyl-;2-[5-(4-Hydroxyphenyl)-3,6-dioxo-2-piperazinyl]-5,5-dimethyl-4-thiazolidinecarboxylic acid;Amoxicillin piperazine-2,5-dione;2,5-Amoxipiperazinedione
94659-47-9 Inquiry

Atorvastatin Acid - Impurity F

Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide;(3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]aMino]-3,5-dihydroxy-heptanoic Acid CalciuM Salt;Atorvastatin IMpurity-E(EP)(USP RCE);Atorvastatin IMpurity-F(EP);Atovastatin Impurity F;Atorvastatin Diamino
1105067-87-5 Inquiry

Atorvastatin Acid - Impurity H

1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-;1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-,(2R-trans)-;5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide;Atorvastatin lactone;Atorvastatin δ-lactone;5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydropyran-2-yl]ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;142062-65-5
125995-03-1 Inquiry

Atorvastatin Calcium Salt

1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),(βR,δR)-;1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),[R-(R*,R*)]-;CI 981;Atorvastatin calcium;YM 548;Lipitor;Atorvastatin hemicalcium;Tahor;Sortis;Atorvastatin hemicalcium salt;Storvas;Rotacor;Atocor;Atoraz;Lowlip;Lorvast;334757-04-9;1108202-55-6;1370463-14-1
134523-03-8 Inquiry

Azithromycin - Impurity J

DesosaMinylazithroMycin;Desosaminylazithromycin (15 mg);(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptaMethyl-11-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one;CP 66458;DesosaMinylazithroMyc
117693-41-1 Inquiry

Azithromycin - Impurity L

Azithromycin N-Oxide (15 mg);(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-;Azithromycin EP Impurity L;Azithromycin 3-N-Oxide
90503-06-3 Inquiry

Cefepime - Related Compound D

4-Thiazoleacetic acid,2-amino-α-(methoxyimino)-,(αZ)-;4-Thiazoleacetic acid,2-amino-α-(methoxyimino)-,(Z)-;(αZ)-2-Amino-α-(methoxyimino)-4-thiazoleacetic acid;Thiazoximic acid;(Z)-2-Amino-α-(methoxyimino)-4-thiazoleacetic acid;2-(2-Amino-4-thiazolyl)-(Z)-2-methoxyiminoacetic acid;syn-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid;2-(2-Aminothiazol-4-yl)-2-(Z)-methoxyiminoacetic acid;2-(2-Aminothiazole-4-yl)-2-(Z)-methoxyiminoacetic acid;(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid;(Z)-(2-Aminothiazol-4-yl)-α-(methoxyimino)acetic acid;syn-Thiazoximic acid;(Z)-(2-Aminothiazol-4-yl)methoxyiminoacetic acid;(Z)-2-Amino-α-(methoxyimino)-4-thiazoleacetic acid;(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid;Ansaiwosuan;79226-89-4
65872-41-5 Inquiry

Cefpodoxime Proxetil

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester,(6R,7R)-;CS 807 (pharmaceutical);CS 807;Cefpodoxime proxetil;U 76252;Antibiotic CS 807;RU 51807;Banan;(RS)-1-(Isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-[(Z)-(methoxyimino]acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;Orelox;Vantin;Otreon;Cefodox;Cephpodoxime proxetil;Cepodem;Cefoprox;Cefoflam;Simplicef;95242-58-3
87239-81-4 Inquiry

Doxycycline Hyclate

2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride,(4S,4aR,5S,5aR,6R,12aS)-,compd. with ethanol,hydrate (2:2:1:1);2-Naphthacenecarboxamide,4β-(dimethylamino)-1,4,4aβ,5,5aβ,6,11,12a-octahydro-3,5β,10,12,12aβ-pentahydroxy-6β-methyl-1,11-dioxo-,monohydrochloride,compd. with ethyl alc. (2:1),monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,[4S-(4α,4aα,5α,5aα,6α,12aα)]-,compd. with ethanol (2:1),monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-,compd. with ethanol (2:1),monohydrate;Ethanol,compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2),monohydrate;Ethanol,compd. with (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2),monohydrate;Doxycycline hydrochloride hemiethanolate hemihydrate;Doxycycline hyclate;6-Desoxy-5-hydroxytetracycline hydrochloride hemihydrate hemiethanolate;Atridox;Periostat;Monodoks;Tetraclean;BioPure MTAD;62149-53-5;1258072-64-8
24390-14-5 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

China

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.